IMEXHS has signed partnership deal with one of the subsidiaries of Canon medical systems, Vital Images.

United States:  IMEXHS Limited, a company known for offering medical imaging solutions, has entered into a partnership with one of the wholly owned subsidiaries of Canon Medical Systems Corporation, i.e., Vital Systems. As part of the IMEXHS-Vital partnership, Vitrea, which is a multi-modal advanced visualization system by Vital, will be integrated into IMEXHS’ AQUILLA platform.

Vitrea suite of applications is used for 2D, 3D and 4D advanced visualization of data from Computed Tomography, Magnetic Resonance Spectroscopy, X-Ray Angiography, Positon Emission Tomography, Ultrasound and Single Photon Emission Computed Tomography, among others. Its integration in AQUILLA platform is expected to expand the horizon of its sales by increasing the global reach.

The Chief Sales Officer of IMEXHS stated, “Vital is one of the most recognised medical imaging post- processing companies in the market and provides its imaging solutions to several top hospitals around the world. This is a significant agreement for IMEXHS and our full-service imaging capabilities.” He further added, “A global partnership with a company of Vital’s calibre energises our ambitious growth plans into new markets and customer segments. We believe this is the first agreement in a long-term and mutually beneficial partnership.”

According to TechSci Research, this partnership between the two leading medical equipment companies IMEXHS and Vital Images is anticipated to bring out lucrative opportunities for both the companies. Now, IMEXHS customers will be able to perform advanced visualization directly from AQUILLA platform as integration of Vitrea has streamlined the entire process. The partnership is expected to significantly enhance the competitiveness of product offerings from IMEXHS as they can provide better imaging solutions for diagnosis to the physicians, while enhancing the healthcare infrastructure, worldwide.

According to the report published by TechSci Research, “Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems)) By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio &Thoracic, Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2025”, the global diagnostic imaging market is expected to witness steady growth during the forecast period. Diagnostic imaging is the visualization of body organs for timely and early diagnosis and treatment. The market is expected to grow on account of rising geriatric population in the world. In this era, technology and the medical sciences sector have joined hands which has helped people to get better treatments with the help of ultrasound, X-rays, etc. Looking at the utility of diagnostic imaging, governments have now initiated funding for such type of medical devices, which is also a driving factor for this market. However, cost expensiveness and high maintenance can be a hurdle in the growth of the market.

According to the report published by TechSci Research “Global Medical Imaging Monitor Market By Device (Mobile, Desktop, All-in-one), By Panel Size (Under-22.9-inch Panels, 23.0–26.9-inch Panels, 27.0–41.9-inch Panels, Above-42-inch Panels), By Type (Diagnostic Monitors, Surgical Monitors, Clinical Monitors, Others), By Display Color (Monochrome v/s Colored), By Purpose (Doppler, Encoding, Enhanced 3D Reconstruction Contrast Enhancement, Others), By Technology (LED-Backlit LCD, OLED, CCFL-Backlit LCD), By Application (Digital Pathology, Multi-modality, Surgical, Radiology, Mammography, Others), By Region, Competition, Forecast & Opportunities, 2025”, global medical imaging monitor market is expected to grow at a steady pace in the coming years and surpass US$ 58 billion by 2025. Growth in the market is driven by the rising prevalence of chronic diseases, which has increased the demand for emergency healthcare services. This has increased the demand for carrying out various diagnostic procedures such as MRI, sonography, X-ray, among others, before providing any treatment to the patients, thereby positively impacting the market. Besides, increasing adoption of latest diagnostic technologies and continuous advancements in the available healthcare technologies is further anticipated to fuel the market growth over next few years.